Rupatadine富马酸卢帕他定,182349-12-8

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Rupatadine Fumarate

CAS No. : 182349-12-8

MCE 国际站：Rupatadine Fumarate

产品活性：Rupatadine (UR-12592) Fumarate 是一种有效的，具有口服活性的长效 PAF/H1 受体的双抑制剂，K_i 值分别为 0.55 μM 和 0.1 μM。Rupatadine Fumarate 可用于过敏性鼻炎和荨麻疹的研究。

研究领域：Immunology/Inflammation  |  GPCR/G Protein  |  Neuronal Signaling  |  Autophagy

作用靶点：Histamine Receptor  |  Autophagy

In Vitro: Rupatadine Fumarate competitively inhibits histamine-induced guinea pig ileum contraction (pA₂=9.29) without affecting contraction induced by ACh, serotonin or leukotriene D4 (LTD4).
Rupatadine Fumarate competitively inhibits PAF-induced platelet aggregation in washed rabbit platelets (WRP) (pA₂=6.68) and in human platelet-rich plasma (HPRP) (IC₅₀=0.68 μM), while not affecting ADP- or arachidonic acid-induced platelet aggregation.
Rupatadine (0.1-30 μM) Fumarate inhibits TNF-α secretion in a concentration-dependent manner, with maximum values of 92.5%.

In Vivo: Rupatadine Fumarate blocks histamine- and PAF-induced effects in vivo, such as hypotension in rats (ID₅₀=1.4 and 0.44 mg/kg i.v., respectively) and bronchoconstriction in guinea pigs (ID₅₀=113 and 9.6 μg/kg i.v.).
Rupatadine Fumarate potently inhibits PAF-induced mortality in mice (ID₅₀=0.31 and 3.0 mg/kg i.v. and p.o., respectively) and endotoxin-induced mortality in mice and rats (ID₅₀=1.6 and 0.66 mg/kg i.v.).
Rupatadine (6 mg/kg) Fumarate promotes the absorption of the lesions and decreased the density of lungs.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Immunology/Inflammation Compound Library  |  Neuronal Signaling Compound Library  |  FDA-Approved Drug Library  |  Autophagy Compound Library  |  Drug Repurposing Compound Library  |  NMPA-Approved Drug Library  |  Orally Active Compound Library  |  Neurotransmitter Receptor Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Anti-Parkinson's Disease Compound Library  |  Neurodegenerative Disease-related Compound Library  |  Anti-Obesity Compound Library  |  Rare Diseases Drug Library  |  Human Metabolite Library  |  Coagulation and Anti-coagulation Compound Library  |  Heterocyclic Compound Library  |  Off-patent Drug Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Cell Death Library  |  Histamine  |  Clemastine fumarate  |  Terfenadine  |  Amitriptyline hydrochloride  |  Astemizole  |  Cimetidine  |  Loratadine  |  Osthole  |  Mecamylamine hydrochloride  |  Diphenhydramine hydrochloride  |  Desloratadine  |  Doxepin Hydrochloride  |  Perphenazine  |  Ritanserin  |  Promethazine hydrochloride  |  Famotidine  |  Fexofenadine hydrochloride  |  Mianserin hydrochloride  |  (S)-(+)-Dimethindene maleate  |  Cetirizine dihydrochloride  |  Chlorpheniramine maleate  |  Ketotifen fumarate  |  Mepyramine maleate  |  Ranitidine hydrochloride  |  Benztropine mesylate  |  JNJ-7777120  |  Meclizine dihydrochloride  |  Lodoxamide  |  Mirtazapine

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds